Healthcare

Cryosite Limited (ASX:CTE) is an Australian healthcare services company specialising in clinical trial logistics, pharmaceutical storage and biological sample management. The company provides outsourced storage, distribution and related support services to pharmaceutical businesses, biotechnology companies and clinical research organisations. Its operations include temperature-controlled storage, …

Basel Medical Group (NASDAQ:BMGL) was indicated to be down 8.06% in the October 9, 2026 premarket session on the screener, on a displayed price of USD 3.60 andVolumeduring premarket trading of 12,507 shares. The quoted price is the October 8 close, when the shares …

bioAffinity Technologies (NASDAQ:BIAF) was indicated to be down 5.85% in the October 9, 2026 premarket session on the screener, on a displayed price of USD 5.64 and pre-marketVolumeof 13,667 shares. The screener tags an other event. A released headline list demonstrates that on October …

DataMEDS AI (NASDAQ:MEDS) was indicated to be down 5.29% in the October 9, 2026 premarket session on the screener, on a quoted price of USD 3.40 and pre-marketVolumeof 17,377 shares. The displayed price is the October 8 close, when the shares gained USD 0.52, …

Nexalin Technology (NASDAQ:NXL) was indicated to be down 5.11% in the October 9, 2026 premarket session on the screener, on a displayed price of USD 4.11 and pre-market volume of 580 shares. The screener lists no catalyst and a search located no issuer statement …

Picard Medical (NYSEAMERICAN:PMI) was indicated to be down 3.41% in the October 9, 2026 premarket session on the screener, on a displayed price of USD 9.68 and pre-marketVolumeof 497 shares. The screener tags the catalyst as share issuance, but a search located no issuer …

Doximity (NYSE:DOCS) disclosed fiscal first-quarter revenue of USD 156.6 million, an increase of 7%, based on a secondary summary of the issuer statement on October 8, 2026. Net income was USD 24.3 million, compared with USD 53.3 million a year earlier, a drop of …